Please provide your email address to receive an email when new articles are posted on . Statin use reduced proliferative vitreoretinopathy risk by 47% and complex reoperation rate by 48%. All dosing ...
MedPage Today on MSN
Use of PDE5 Inhibitor Tied to Increased Glaucoma Risk
Findings add to existing evidence linking the drug class to ophthalmic conditions ...
Noha Ekdawi, MD, FAAP, explains why pediatric myopia demands individualized, progression-based management—detailing how they sequence spectacle defocus lenses, low-dose atropine, and specialty ...
Although there are not a lot of articles out there on the possible correlation between the COVID vaccine and my health issues ...
VOICEcorps is a free broadcast reading service for central Ohio residents with low vision, blindness or print disabilities.
The FDA has cleared an IND for RAG-1C, a first-in-class saRNA therapy targeting proliferative vitreoretinopathy.
After multiple UPSC failures and retinal surgery, Parth Chavda secured AIR 932 in UPSC 2023 and joined the Indian Revenue ...
Vietnam Investment Review on MSN
Ractigen wins FDA IND clearance for saRNA candidate
NANTONG, China, July 31, 2026 /PRNewswire/ -- Ractigen Therapeutics, a pioneer and global leader in small activating RNA (saRNA) therapeutics, today announced that the U.S. Food and Drug ...
Biocon Limited has announced the commercial launch of Yesafili (aflibercept-jbvf) in the United States, expanding its ...
The NHS has issued a message on its website for anyone worried about their eyesight. And with many people searching Google ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results